Atlas Trials

Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer

Clinical trial NCT06809426 · COMPLETED

Trial details

NCT number
NCT06809426
Sponsor
Affiliated Hospital of Jiangnan University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
PSMA PET-Positive Castration-Resistant Prostate Cancer
Start date
2023-08-21
Primary completion
2024-10-14
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.